Brent Ristow, CEO of Brighton Ashford, leverages his legal and scientific expertise to ensure FDA compliance for pharmaceuticals and medical devices. With a background in law and a Ph.D. in Organic Photochemistry, Brent Ristow's company delivers meticulous testing conforming to Title 21 standards and cGMP guidelines. Trusted by Fortune 500 firms and startups alike, Brighton Ashford exceeds regulatory expectations under Ristow's leadership. From performance testing to regulatory submissions, Brent Ristow's blend of legal acumen and scientific rigor sets Brighton Ashford apart in the industry.
-
3 المنشورات
-
2 الصور
-
0 الفيديوهات
-
01/01/1985
-
متابَع بواسطة 1 أشخاص
البحث
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
